2008 Facility of the Year Awards (FOYA) Winners Announced
Five pharmaceutical manufacturing facilities constructed by companies located in Germany, Switzerland, and the United States have been selected as Category Winners in the fourth annual Facility of the Year Awards program sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine. The companies and respective award categories include: - Boehringer Ingelheim Pharma GmbH & Co.KG, located in Biberach, Germany, winner of the Facility of the Year Award for Facility Integration - Bristol-Meyers Squibb, located in New Brunswick, New Jersey, USA, winner of the Facility of the Year Award for Equipment Innovation - IDT Biologika GmbH, located in Dessau-Rosslau, Germany, winner of the Facility of the Year Award for Operational Excellence - Pfizer, located in Illertissen, Germany, winner of the Facility of the Year Award for Process Innovation - F. Hoffmann La Roche AG, located in Basel, Switzerland, winner of the Facility of the Year Award for Project Execution The Facility of the Year Awards (FOYA) program recognizes stateof-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high-quality medicines. Now in its fourth year, the Awards Program effectively spotlights the accomplishments, shared commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of all global consumers.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Bayer and Ortho-McNeil, Inc. Outline Phase III Study Program of Oral Factor Xa Inhibitor Rivaroxaban in Chronic Indications - Patient Recruitment for Phase III Clinical Trial to Start in Studies of Oral Anticoagulant in Chronic Indications
Nuevolution A/S and Biovitrum AB in drug discovery collaboration
Novavax and Bharat Biotech announce a pandemic influenza vaccine development alliance
Aspreva announces restructuring designed to drive long-term growth
Crucell and NIH extend Ebola Vaccine Agreement
POC immunoassay for hCG
Enzymes open up new avenues in the chemical industry - BASF steps up White Biotechnology operations

STARLIMS Netherlands B.V. - Alkmaar, Netherlands
